Metabolic syndrome in first episode schizophrenia — A randomized double-blind controlled, short-term prospective study
Authors:
- Sahoo SaddichhaSSSahoo Saddichha
- Narayana ManjunathaNMNarayana Manjunatha
- Shahul AmeenSAShahul Ameen
- Sayeed AkhtarSASayeed Akhtar
- 1 April 2008
- journal article
- clinical trial
- Published by Elsevier in Schizophrenia Research
- Vol. 101 (1-3) , 266-272
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: Results of the CLAMORS StudySchizophrenia Research, 2007
- Differential metabolic effects of antipsychotic treatmentsEuropean Neuropsychopharmacology, 2006
- Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medicationSchizophrenia Research, 2006
- Schizophrenia: who is at risk? Who is a case?International Clinical Psychopharmacology, 2006
- The metabolic syndromeThe Lancet, 2005
- Prevalence of the metabolic syndrome and overweight among adults in ChinaThe Lancet, 2005
- Belgian consensus on metabolic problems associated with atypical antipsychoticsInternational Journal of Psychiatry in Clinical Practice, 2005
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesCirculation, 2004
- P.2.084 A comparison of olanzapine and risperidone for the schizophrenic patients intolerance of neuroleptic-induced extrapyramidal syndromes (EPS)European Neuropsychopharmacology, 2003
- Physical Health of the Long-Term Mentally Ill in the CommunityThe British Journal of Psychiatry, 1989